22
Total investments
4
Early stage
10
Mid stage
6
Late stage
5y
Years active
Portfolio
21 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Dec 2024
Biomemory is a deep-tech company specialized in enterprise data storage. It leverages molecular engineering to build cost-effective and energy-efficient exabyte rackable appliances for Data Centers.
Biomemory also develops high-quality DNA-based anti-counterfeiting systems with minimal ecological impact.
Contact us: contact@biomemory.com
Jobs and internships: jobs@biomemory.com
Private Investor
Sep 2024
Bus stops. Traffic jams. Empty docks.
Life’s too short... and you were made to move. Which is why the moment has come for a movement. To unchain the city and give you free rein: whoever you are and wherever you’re going. A movement powered by Pony.
No docking. No hassle. No limits.
Not just getting around.
Changing the way the world goes round.
Private Investor
Aug 2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology.
At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women.
Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine.
Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability.
Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future.
🌐 www.ziwig.com
Private Investor
Mar 2024
Finovox, the Document Verification Software
🔹 Document Processing: Handle all your documents (OCR/ICR, consistency checks, business rules) to accelerate your workflows and reduce costs.
🔹 Fraud Analysis: Instantly detect frauds that are invisible to the naked eye.
🔹 Case Investigation: Investigate, justify, and collaborate efficiently on every case.
Learn more on our website: https://www.finovox.com/en
Private Investor
Mar 2024
Yumgo cest la première vraie solution végétale, pour remplacer les œufs dans les recettes. Créé par un chef et pour les chefs. Pour un résultat inratable, gourmand et de qualité 🌱
Des produits imaginés pour répondre aux enjeux des professionnels de la gastronomie, et faciliter la transition des chefs vers le végétal: une utilisation simple (identique aux œufs), un résultat savoureux, beau, éthique, fiable et de qualité.
Private Investor
Jan 2024
Latitude is a pioneering French rocket launch company on a mission to push the boundaries of space technologies, fostering a better and brighter future for all. With our 20m height Zephyr launcher, we strive to create innovative and sustainable solutions for space exploration and development, while placing human experiences at the core of our journey.
Our team is driven by the values of optimism, innovation, collaboration, perseverance, and boldness. At Latitude, we believe in the power space exploration and the limitless possibilities it offers. Were not just launching rockets; were launching dreams and building the foundation for a more resilient and inspired world.
As we embark on this cosmic adventure, our warm and authentic approach brings a sense of belonging and togetherness, making space more accessible and inviting for you. Our motto, "Bienvenue in your space," reflects our commitment to creating a more inclusive and diverse space community.
Join us at Latitude and be part of our dynamic, collaborative team that is redefining the future of space exploration. Lets shape the cosmos together, one launch at a time.
Explore career opportunities at latitude.eu/jobs and be part of our cosmic journey.
Private Investor
Nov 2023
Leader en France des paniers de fruits et légumes anti gaspi
Plus de 50 tonnes de légumes sauvés chaque jour
Déjà 1 million de paniers sauvés en à peine 18 mois
+ de 300 millions de vue sur lapplication anti gaspi too good to go !
Private Investor
Sep 2023
Finishers : le premier moteur de recherche de course à pied en France et dans le monde entier ! Trouver et réserver son prochain dossard naura jamais été aussi simple.
Private Investor
Aug 2023
Founded in 2014, Innovorder is the leader in digital solutions for the food service industry and counts some of the largest players in the commercial and institutional catering sectors as customers.
Innovorder’s comprehensive SaaS software suite enables the deployment of new order channels, the management of both a restaurant networks and single points of sale, the acceleration of order and kitchen preparation while optimizing production management, sales monitoring and customer loyalty.
6 years after its creation, Innovorder has more than 800 customers and thousands of points of sale using the Innovorder solution, including industry leaders such as KFC, Big Fernand, Quick, Bagel Corner, Courtepaille, Agapes, Amorino, and Poivre Rouge. Innovorder also provides its solution to the largest Contract Catering companies such as Elior, Compass, Api Restauration, Convivio and Dupont Restauration.
Based in Paris, France, the company acquired the start-up La Caisse Tactile in October 2016. It employs more than 60 people and has completed two major rounds of fundraising, the latest in July 2019, for a total of more than 10 million euros.
Private Investor
Jul 2023
Wheere is a French deeptech company revolutionizing indoor geolocation.
Our technology is the only one capable of covering a site of one square kilometer with just four transmitters.
By leveraging unmodulated low-frequency waves and a unique algorithm, our solution penetrates even the densest obstacles, such as concrete walls, and offers a sub-meter accuracy.
Founded in 2021 by Pierre-Arnaud Coquelin and Antoine Carrabin, Wheere successfully closed an €11 million seed round in July 2023.
At Wheere, our mission is to make indoor geolocation as accessible as GPS—ubiquitous, affordable, and integrated into all B2C and B2B devices.
To achieve this, we have two key milestones ahead:
- By 2027: Reduce the size, energy consumption, and production costs of our receivers.
- By 2030: Achieve global availability of our technology through the spatial deployment of our #LEOPNT transmitters.
Private Investor
Jul 2023
At Tilak, our vision is to transform the way we monitor chronic eye conditions. Our mission is to empower patients with fun and easy-to-use apps that help them (and their doctors’!) better manage their diseases. Founded in 2016 by Pr. José-Alain Sahel (opthalmologist) and Edouard Gasser (ex-Gameloft), Tilaks DNA combines medical expertise with gaming mastery. “You Play, We Care.”
Our product is OdySight, the worlds first medical mobile app for vision monitoring supported by a national healthcare system. Since its launch on the French market in 2018, OdySight has been prescribed to 15 000 patients, most of which in France. OdySight is a CE marked medical device available in 5 languages and available on app stores in France, Spain, Belgium and the US.
Private Investor
May 2023
Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.
Private Investor
May 2023
Since 1999, a lot of international studies have proven the benefits of physical activities and teambuilding events on companies’ competitivity and profitability.
Squadeasy is an “all-in-one” mobile and web platform that allows firms to place at their employees disposal a ludic and connected running competition by teams. Every employee can participate, whether they are spread all around the world, sportsmen/women or not, as far as they have a personal or professional smartphone.
Squadeasy slogan is :“ the company’s health is driven by the one of its’ employees.
Squadeasy is directly inspired from SquadRunner’s success, a B2C running application that is used over 83 countries. Indeed, SquadRunner is known as the first international running competition that has been able to imply gamification and team spirit.
Squadeasy has adapted the concept to companies’ needs and involvement in their CSR’s (Corporate Social Responsibility) strategy. It is a mobile application on iPhone or Android, as a white label, that offers a unique experience to each collaborator.
Squadeasy technological tools are impressive :
- instant messaging between participants, but also between organizers and participants.
- Internal GPS tracker : real-time speed, distance, map, and graphics.
- Connection to other trackers (applications and connected watches)
Squadeasy and SquadRunner’s mechanisms are directly inspired from scientific theories on motivation and more precisely accomplishments of aims.
Squadeasy and SquadRunner are services offered by LiveHappier, a Paris based company created by a ten years experienced team in various areas such as R&D, finance, art, sport, IT development and car industry.
Private Investor
Apr 2023
Aujourd’hui, 25% de lempreinte carbone mondiale provient des échanges internationaux : ils génèrent énormément d’émissions pour trop peu d’actions mises en place.
Keewe, c’est la fintech pour des échanges internationaux plus simples et plus durables. On pense que l’action écologique ne doit pas être un coût à subir mais un avantage compétitif pour embarquer les entreprises.
On agit sur
- l’impact : on mesure l’empreinte carbone des opérations tout en générant de l’impact positif
- le prix : on est ultra compétitifs et transparents par rapport au marché bancaire et aux autres fintech
- la simplicité : c’est facile, intuitif. Tous les services financiers internationaux sont au même endroit.
Pour convaincre, on doit simplifier. L’impact ne doit pas être une charge supplémentaire. Les entreprises n’ont rien à faire: on est là pour accompagner.
____________________________________________________________________________
Lauréat de Scale up Excellence de la French Tech
Prix coup de ❤ du Challenge Fintech for Tomorrow 2019
Labellisé Envol! : https://www.envol-entreprise.fr/
Et accéléré par WILCO (https://www.wilco-startup.com/)
www.keewe.eu
Show all 21 investments ↓
Experience · 22 entries
All (22)
Investments (22)
2024
Private Investor
Dec 2024
Biomemory is a deep-tech company specialized in enterprise data storage. It leverages molecular engineering to build cost-effective and energy-efficient exabyte rackable appliances for Data Centers.
Biomemory also develops high-quality DNA-based anti-counterfeiting systems with minimal ecological impact.
Contact us: contact@biomemory.com
Jobs and internships: jobs@biomemory.com
Private Investor
Sep 2024
Bus stops. Traffic jams. Empty docks.
Life’s too short... and you were made to move. Which is why the moment has come for a movement. To unchain the city and give you free rein: whoever you are and wherever you’re going. A movement powered by Pony.
No docking. No hassle. No limits.
Not just getting around.
Changing the way the world goes round.
Private Investor
Aug 2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology.
At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women.
Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine.
Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability.
Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future.
🌐 www.ziwig.com
Private Investor
Mar 2024
Finovox, the Document Verification Software
🔹 Document Processing: Handle all your documents (OCR/ICR, consistency checks, business rules) to accelerate your workflows and reduce costs.
🔹 Fraud Analysis: Instantly detect frauds that are invisible to the naked eye.
🔹 Case Investigation: Investigate, justify, and collaborate efficiently on every case.
Learn more on our website: https://www.finovox.com/en
Private Investor
Mar 2024
Yumgo cest la première vraie solution végétale, pour remplacer les œufs dans les recettes. Créé par un chef et pour les chefs. Pour un résultat inratable, gourmand et de qualité 🌱
Des produits imaginés pour répondre aux enjeux des professionnels de la gastronomie, et faciliter la transition des chefs vers le végétal: une utilisation simple (identique aux œufs), un résultat savoureux, beau, éthique, fiable et de qualité.
Show all 22 entries ↓
Investment activity
2021–2024 · 22 investments
Recent (last 2 years)Earlier